Secondary open-angle glaucoma is frequently refractory and difficult to manage. 1 Glaucoma is uncommon in scleritis, but may develop due to permanent damage to the trabecular meshwork even in quiescent scleritis. 2 Posterior scleritis has been reported to cause angle-closure glaucoma. [3] [4] [5] [6] Other mechanisms include secondary steroid-induced glaucoma, peripheral anterior synechiae, and angle neovascularisation.
Scleritis has been reported following surgical trabeculectomy. 7 
Case report
A 68-year-old Caucasian patient had been followed up for 14 years with recurrent bilateral sectoral anterior non-necrotising scleritis in the absence of underlying systemic disease.
The intraocular pressure (IOP) had been controlled with topical g.Timolol 0.5% BD for the previous 5 years. Five months prior to surgery, IOP increased to 30 mm Hg. Despite maximal medical treatment (g.Bimatoprost/ Timolol (Ganfort), g.Brinzolamide (Azopt), and Acetazolamide SR 250 mg p.o. BD) her IOP remained at 39 mm Hg. This was associated with a cup-disc ratio of 0.85 and predominantly nasal superior and inferior visual field defects (Figure 1 ).
This patient was surgically challenging due to the presence of diffuse scleromalacia (Figures 2 and 3 Correspondence 104 Eye 
Comment
This patient's surgery was successful despite significant challenges and a known risk of scleritis resulting from the procedure itself. Oral Prednisolone was prescribed post-operatively, which was key in preventing the recurrence of scleritis in this patient.
Releasable sutures were used ( Figure 3 (arrow B) ), ensuring a low risk of hypotony immediately preoperatively. The alternative of laser suture lysis would carry an increased risk of scleral perforation with such thin sclera.
Careful surgical planning, with judicious use of corticosteroids, can result in excellent surgical outcomes in patients with scleritis and secondary glaucoma. There appears to be, however, a misconception between the usage of intracameral cefuroxime and its perceived protective effect against PE secondary to enterococci. Cefuroxime is a second-generation cephalosporin with an intrinsic lack of activity against enterococci owing to the production of low-affinity penicillin binding proteins and L,Dtranspeptidase. 2, 3 This is commonly referred to as the 'enterococci-gap'.
WH
Putting this into the broader picture of the quoted EVS 4 vs the Swedish National Cataract Register Study, 5 the a priori lack of efficiency of cefuroxime against enterococci explains the higher prevalence of enterococciinduced PE in the Swedish group (29.9% vs 2.2%) and is not surprising.
Given that enterococci-induced PE is a considerable problem in the era of intracameral cefuroxime, it seems counterintuitive that the authors' standard choice for topical preoperative prophylaxis is a combination of Polymyxin B and Trimethoprim, both of which have low effectiveness against enterococci. Topical Chloramphenicol would seem a superior choice in this context.
It would have been interesting to know which species of bacteria the cluster of four PEs in 2005/2006 belonged to and whether intracameral cefuroxime had been given.
